Scott A Barman
Overview
Explore the profile of Scott A Barman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
888
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Li X, Yu Y, Gorshkov B, Haigh S, Bordan Z, Weintraub D, et al.
Front Immunol
. 2018 Jun;
9:1309.
PMID: 29951058
Pneumonia is a leading cause of death in children and the elderly worldwide, accounting for 15% of all deaths of children under 5 years old. is a common and aggressive...
12.
Barman S, Chen F, Li X, Haigh S, Stepp D, Kondrikov D, et al.
Am J Respir Crit Care Med
. 2018 Jan;
197(11):1488-1492.
PMID: 29365276
No abstract available.
13.
Barman S, Fulton D
Adv Exp Med Biol
. 2017 Oct;
967:1-11.
PMID: 29047077
Pulmonary arterial hypertension (PAH) is a progressive disease arising from remodeling and narrowing of pulmonary arteries (PA) resulting in high pulmonary arterial blood pressure and ultimately right ventricular failure. Elevated...
14.
Fulton D, Li X, Bordan Z, Haigh S, Bentley A, Chen F, et al.
Antioxidants (Basel)
. 2017 Jul;
6(3).
PMID: 28684719
Pulmonary arterial hypertension (PAH) is a progressive disease of the lung vasculature that involves the loss of endothelial function together with inappropriate smooth muscle cell growth, inflammation, and fibrosis. These...
15.
Chen F, Li X, Aquadro E, Haigh S, Zhou J, Stepp D, et al.
Free Radic Biol Med
. 2016 Aug;
99:167-178.
PMID: 27498117
Excessive levels of reactive oxygen species (ROS) and increased expression of NADPH oxidases (Nox) have been proposed to contribute to pulmonary artery hypertension (PAH) and other cardiovascular diseases (CVD). Nox...
16.
Fulton D, Barman S
Arterioscler Thromb Vasc Biol
. 2016 Mar;
36(4):579-81.
PMID: 27010024
No abstract available.
17.
Barman S, Chen F, Su Y, Dimitropoulou C, Wang Y, Catravas J, et al.
Arterioscler Thromb Vasc Biol
. 2014 Jun;
34(8):1704-15.
PMID: 24947524
Objective: Pulmonary hypertension (PH) is a progressive disease arising from remodeling and narrowing of pulmonary arteries (PAs) resulting in high pulmonary blood pressure and ultimately right ventricular failure. Elevated production...
18.
Pandey D, Patel A, Patel V, Chen F, Qian J, Wang Y, et al.
Am J Physiol Heart Circ Physiol
. 2012 Mar;
302(10):H1919-28.
PMID: 22427510
The expression and functional significance of NADPH oxidase 5 (Nox5) and its five isoforms in vascular cells is poorly understood. The goal of this study was to determine whether Nox5-α,...
19.
Yu X, Ma H, Barman S, Liu A, Sellers M, Stallone J, et al.
Am J Physiol Endocrinol Metab
. 2011 Jul;
301(5):E882-8.
PMID: 21791623
Estrogens can either relax or contract arteries via rapid, nongenomic mechanisms involving classic estrogen receptors (ER). In addition to ERα and ERβ, estrogen may also stimulate G protein-coupled estrogen receptor...
20.
White R, Gerrity R, Barman S, Han G
Steroids
. 2010 Jan;
75(11):788-93.
PMID: 20060403
Although early studies demonstrated that exogenous estrogen lowered a woman's risk of cardiovascular disease, recent trials indicate that HRT actually increases the risk of coronary heart disease or stroke. However,...